podophyllotoxin has been researched along with Bladder Cancer in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (96.43) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Płuzańska, A; Robak, T | 1 |
| Fujita, K; Murayama, T; Sayama, T | 1 |
| Oliver, RT; Ponder, BA | 1 |
| Dalesio, O; de Pauw, M; Denis, L; Robinson, M; Schulman, CC; Smith, P; Sylvester, R; Viggiano, G | 1 |
| Abbou, C; Auvert, J; Botto, H; Garcia-Giralt, E; Hannoun, M; Jouve, M; Lachand, AT; Morin, P; Palangie, T; Pouillart, P | 1 |
| Allam, N; Breillout, F; Debal, V; Gourdier, B; Manfait, M; Millot, JM; Morjani, H | 1 |
| El-Morsi, B; El-Sebai, IT; Gad-el-Mawla, NM; Hamza, MR; Khafagy, M; Mansour, MA; Muggia, FM; Sherif, M | 1 |
| De Pauw, M; Denis, L; Lachand, A; Pavone-Macaluso, M; Robinson, M; Schulman, C; Smith, P; Staquet, M; Sylvester, R | 1 |
| Falkson, G; Falkson, HC; van den Bergh, JA; van der Merwe, AM; van Dyk, JJ; van Eden, EB | 1 |
| Henney, JE; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
| Soloway, MS | 1 |
| Caramia, G; Messana, V; Pavone-Macaluso, M; Rizzo, FP | 1 |
| Martino, C; Soloway, MS | 1 |
| Kenis, Y; Rozencweig, M; Schulman, CC; Staquet, M; Sylvester, R | 1 |
| Mechl, Z; Rovný, F; Sopková, B | 1 |
| Niell, HB; Soloway, MS; Wood, CA | 1 |
| Aso, Y; Fukushima, M; Matsuura, O; Naide, Y; Ohshima, S; Ono, Y; Ota, K; Suzuki, K; Tajima, A; Ushiyama, T | 1 |
| Berenberg, J; Blumenstein, BA; Bukowski, RM; Johnson, K; O'Bryan, RM; Oishi, N; Quagliana, J; Rivkin, SE; Saiers, JH; Stephens, RL | 1 |
| Suzuki, K | 1 |
| Aota, Y; Kinjo, T; Mitsuya, H; Murase, T; Shimoji, T | 1 |
| Biondo, F; Caramia, G; Gebbia, N; Pavone-Macaluso, M; Rausa, L; Rizzo, FP | 1 |
| Carter, SK; Goldsmith, MA | 1 |
| BAN'KOVSKII, NS; FEDOROV, IV; SHEVTSOV, IP; ZAITSEV, NG | 1 |
| FIRSTATER, M | 1 |
| HVIDT, V | 1 |
| Messmer, B | 1 |
3 review(s) available for podophyllotoxin and Bladder Cancer
| Article | Year |
|---|---|
VM 26 and VP 16-213: a comparative analysis.
Topics: Animals; Brain Neoplasms; Drug Evaluation; Etoposide; Humans; Kinetics; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1977 |
Intravesical and systemic chemotherapy of murine bladder cancer.
Topics: Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Ethoglucid; FANFT; Female; Fluorouracil; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Thiotepa; Urinary Bladder Neoplasms | 1977 |
4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26)--a brief review.
Topics: Alopecia; Animals; Brain Neoplasms; Clinical Trials as Topic; DNA; Glycosides; Hodgkin Disease; Humans; Hypotension; Leukopenia; Mitosis; Neoplasms, Experimental; Podophyllotoxin; Solubility; Structure-Activity Relationship; Thiophenes; Urinary Bladder Neoplasms | 1973 |
8 trial(s) available for podophyllotoxin and Bladder Cancer
| Article | Year |
|---|---|
[New antineoplastic drugs of the podophyllotoxin derivative group].
Topics: Adult; Child; Clinical Trials as Topic; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1983 |
Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone.
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1982 |
Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26.
Topics: Adolescent; Adult; Aged; Altretamine; Carcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middle Aged; Podophyllotoxin; Schistosomiasis; Teniposide; Triazines; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1978 |
Adjuvant therapy of T1 bladder carcinoma: preliminary results of an EORTC randomized study.
Topics: Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Pathology; Podophyllotoxin; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1978 |
Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Drug Evaluation; Humans; Infusions, Parenteral; Leiomyosarcoma; Male; Mitosis; Neoplasm Metastasis; Podophyllotoxin; Prostatic Neoplasms; Teniposide; Teratoma; Testicular Neoplasms; Therapeutic Irrigation; Urinary Bladder Neoplasms | 1975 |
EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma.
Topics: Carcinoma, Papillary; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Postoperative Care; Remission, Spontaneous; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1976 |
4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26)--a brief review.
Topics: Alopecia; Animals; Brain Neoplasms; Clinical Trials as Topic; DNA; Glycosides; Hodgkin Disease; Humans; Hypotension; Leukopenia; Mitosis; Neoplasms, Experimental; Podophyllotoxin; Solubility; Structure-Activity Relationship; Thiophenes; Urinary Bladder Neoplasms | 1973 |
Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Anemia, Aplastic; Antineoplastic Agents; Blood Platelet Disorders; Child; Clinical Trials as Topic; Female; Gastrointestinal Diseases; Glycosides; Hematopoiesis; Hodgkin Disease; Humans; Lactones; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Remission, Spontaneous; Thiophenes; Urinary Bladder Neoplasms | 1972 |
18 other study(ies) available for podophyllotoxin and Bladder Cancer
| Article | Year |
|---|---|
[Effect of etoposide for pulmonary metastases from urogenital tract cancer].
Topics: Adenocarcinoma; Administration, Oral; Aged; Carcinoma, Transitional Cell; Etoposide; Humans; Infusions, Parenteral; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 1984 |
Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Evaluation; Etoposide; Humans; Infusions, Parenteral; Middle Aged; Podophyllotoxin; Urinary Bladder Neoplasms | 1984 |
Combined chemotherapy in the management of metastatic bladder cancer.
Topics: Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Mitomycins; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1981 |
[Characterization of the mechanism of cross-resistance to vinca alkaloids and taxoids in the human J82 bladder tumor cell line].
Topics: Antineoplastic Agents; Carcinoma; Colchicine; Doxorubicin; Drug Resistance, Multiple; Gene Expression Regulation, Neoplastic; Humans; Paclitaxel; Phenotype; Podophyllotoxin; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine; Vinorelbine | 1994 |
Single-drug chemotherapy of bladder cancer with adriamycin, VM-26 or bleomycin. A phase II multicentric, co-operative study.
Topics: Bleomycin; Doxorubicin; Humans; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1976 |
A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Administration, Oral; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Glucosides; Humans; Leukemia, Myeloid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Mesothelioma; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Urinary Bladder Neoplasms | 1975 |
Prophylaxis of bladder tumor implantation. Intravesical and systemic chemotherapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Disease Models, Animal; Doxorubicin; Female; Methylnitrosourea; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1976 |
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
Topics: Carcinoma, Papillary; Humans; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide; Time Factors; Urinary Bladder Neoplasms | 1977 |
Effect of concentration and time of drug exposure on clonal growth of murine bladder cancer.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cell Line; Cisplatin; Colony-Forming Units Assay; Disease Models, Animal; Doxorubicin; FANFT; Female; Fluorouracil; Maytansine; Methotrexate; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Podophyllotoxin; Streptozocin; Time Factors; Trichothecenes; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1985 |
[Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract].
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Podophyllotoxin; Teniposide; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1988 |
Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
Topics: Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Male; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1987 |
[Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
Topics: Adult; Aged; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1986 |
[Effect of etoposide for urogenital tumors].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pancreatic Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Rhabdomyosarcoma; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1985 |
Experimental techniques for testing the sensitivity of bladder tumours to antineoplastic drugs.
Topics: Administration, Topical; Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Nucleus; Cricetinae; Cytotoxicity Tests, Immunologic; Daunorubicin; Demecolcine; DNA, Neoplasm; Doxorubicin; Drug Resistance; Fluorescence; Glycosides; Humans; Melphalan; Microscopy, Fluorescence; Neoplasm Transplantation; Oxidoreductases; Podophyllotoxin; Protein Biosynthesis; Thiophenes; Thiotepa; Transplantation, Heterologous; Urinary Bladder Neoplasms | 1973 |
[The use of podophyllum for treatment of bladder tumors].
Topics: Podophyllum; Urinary Bladder Neoplasms | 1962 |
Podophyllin in the treatment of vesical papillomas.
Topics: Carcinoma; Carcinoma, Papillary; Humans; Papilloma; Podophyllin; Podophyllum; Urinary Bladder Neoplasms | 1961 |
[Podophyllin treatment of bladder tumors].
Topics: Papilloma; Podophyllin; Podophyllum; Urinary Bladder Neoplasms | 1962 |
[Plasma iron turnover before and following cytostatic therapy and its signifiance as indicator of tumor activity].
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Follow-Up Studies; Humans; Iron; Iron Isotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Prostatic Neoplasms; Rectal Neoplasms; Thyroid Neoplasms; Time Factors; Urinary Bladder Neoplasms | 1968 |